When stratifying GBMs based on mutational status of IDH1/2, no significant differences in EGR1 or EGR3 protein levels were found in IDH1/2 wildtype vs. IDH1/2 mutated tumours (Fig. 1D). This evidence concerns the gene EGR1 and neoplasm.